" class="no-js "lang="en-US"> Thomas Breuer - Medtech Alert
Tuesday, July 29, 2025
Thomas Breuer

Thomas Breuer

About Thomas Breuer

Passionate advocate for improving life of individuals of all ages, as well as overall public health, by turning vaccines into vaccination.

With a career spanning both the public and private sector, I flex science and a focus on the patient into a business context (and vice versa), synthesizing my public health experience into know-how for developing and commercializing vaccines.

Skillset to orchestrate complex situations to a fruitful conclusion in a calm and rational manner, whether under high pressure or within context of major strategic decision making at company level.

Related Story

WHO Grants Prequalification to GSK’s Mosquirix – the First and Only Approved Malaria Vaccine

September 8 2022

GSK plc (LSE/NYSE: GSK) announced today that the World Health Organization (WHO) has awarded prequalification […]

GSK Announces £1 Billion R&D Investment Over Ten Years to Get Ahead of Infectious Diseases in Lower-income Countries

June 27 2022

GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate […]